Evidence map›Paper›PMID 34339338›Full record

ArticleVirulence2021

Abrogation of the RNase activity of E

Miaomiao Wang, José Alejandro Bohórquez, Yoandry Hinojosa, Sara Muñoz-González, Markus Gerber, Liani Coronado, Carmen Laura Perera, Matthias Liniger, Nicolas Ruggli, Llilianne Ganges

Open access · goldAbstract read
In one paragraph

Article in Virulence, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Removal of the EJournal of virology · 2022
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Miaomiao WangOIE Reference Laboratory for Classical Swine Fever, IRTA-CReSA, Barcelona, Spain.
José Alejandro BohórquezOIE Reference Laboratory for Classical Swine Fever, IRTA-CReSA, Barcelona, Spain.
Yoandry HinojosaDivision of Virology, Institute of Virology and Immunology IVI, Mittelhäusern, Switzerland.
Sara Muñoz-GonzálezOIE Reference Laboratory for Classical Swine Fever, IRTA-CReSA, Barcelona, Spain.
Markus GerberDivision of Virology, Institute of Virology and Immunology IVI, Mittelhäusern, Switzerland.
Liani CoronadoCentro Nacional De Sanidad Agropecuaria (CENSA), Mayabeque, Cuba.
Carmen Laura PereraCentro Nacional De Sanidad Agropecuaria (CENSA), Mayabeque, Cuba.
Matthias LinigerDivision of Virology, Institute of Virology and Immunology IVI, Mittelhäusern, Switzerland.
Nicolas RuggliDivision of Virology, Institute of Virology and Immunology IVI, Mittelhäusern, Switzerland.
Llilianne GangesOIE Reference Laboratory for Classical Swine Fever, IRTA-CReSA, Barcelona, Spain.
Centre de Recerca en Sanitat Animal · ESUniversity of Bern · CHCentro Nacional de Sanidad Agropecuaria · CUInstitute of Virology of the Slovak Academy of Sciences · SK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence of low virulence classical swine fever virus (CSFV) strains makes viral eradication difficult in endemic countries. However, the determinants for natural CSFV attenuation and persistence in the field remain unidentified. The aim of the present study was to assess the role of the RNase activity of CSFV E

Indexed as

Classical Swine FeverClassical Swine Fever VirusImmunity, HumoralRibonucleasesAnimalsPersistent InfectionSwineVirulenceRibonucleasesClassical swine fever virus (CSFV)Erns RNase activityhumoral responsePestivirustype I IFNviral attenuationviral persistenceviral replicationviral transmission

Identifiers

PMID34339338
PMCPMC8331007
OpenAlexW3192949789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.